Markets:

Overview

News

Currencies

International

Treasuries

Neuronetics, Inc. - Common Stock (NQ:STIM)

1.310 +0.010 (+0.77%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Neuronetics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Top 3 Health Care Stocks Which Could Rescue Your Portfolio In November ↗

November 18, 2025

Via Benzinga

TRICARE West Expands NeuroStar® TMS Coverage to Include Adolescents Aged 15+ Struggling with Depression

November 12, 2025

New Policy Update Brings Innovative, Non-Drug Depression Treatment to Adolescents Across 26 States

From Neuronetics

Via GlobeNewswire

Tuesday's pre-market session: top gainers and losers ↗

November 04, 2025

The US market session of Tuesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.

Via Chartmill

Earnings Scheduled For November 4, 2025 ↗

November 04, 2025

Via Benzinga

Earnings Scheduled For August 5, 2025 ↗

August 05, 2025

Via Benzinga

Earnings Scheduled For May 6, 2025 ↗

May 06, 2025

Via Benzinga

Earnings Scheduled For November 12, 2024 ↗

November 12, 2024

Via Benzinga

NEURONETICS INC (NASDAQ:STIM) Stock Plummets 22% on Q3 2025 Revenue Miss ↗

November 04, 2025

Neuronetics (STIM) Q3 2025 results: revenue miss sparks a 22% stock drop despite a narrower-than-expected EPS loss.

Via Chartmill

Neuronetics Announces Three-Year Exclusive Partnership with Elite DNA Behavioral Health to Expand NeuroStar Access and Operational Excellence

October 30, 2025

New collaboration provides services to streamline patient support, reduce administrative burden, and expand access to advanced TMS treatment across Elite DNA Clinics

From Neuronetics

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's After-Market Session ↗

October 06, 2025

Via Benzinga

New York State Medicaid Expands Coverage for TMS Therapy, Including NeuroStar® Advanced Therapy, to Treat Major Depressive Disorder (MDD)

September 17, 2025

Over 5 million New York Medicaid members to gain access to Transcranial Magnetic Stimulation (TMS) services

From Neuronetics

Via GlobeNewswire

Neuronetics Inc (NASDAQ:STIM) Reports Mixed Q2 2025 Earnings: Revenue Beat Overshadowed by Wider-Than-Expected Loss ↗

August 05, 2025

Neuronetics (STIM) reported mixed Q2 2025 results, beating revenue estimates but posting a wider-than-expected loss, causing a 9% pre-market drop. Greenbrook clinics hit record revenue.

Via Chartmill

NeuroStar Announces New Publication in JAACAP Open Highlighting Treatment Efficacy in Depressed Adolescents

July 30, 2025

Real-world data showing NeuroStar is effective in adolescents and young adults with depression from the world’s largest TMS outcomes dataset

From Neuronetics

Via GlobeNewswire

Neuronetics Announces Clinical Presence at the 2025 Clinical TMS Society Annual Meeting and Progress in Greenbrook’s Personalized Care Trial Program

June 10, 2025

NeuroStar, a Silver Sponsor at CTMSS, will also present two posters as part of the Company’s ongoing commitment to clinical innovation and excellence

From Neuronetics

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

May 27, 2025

Via Benzinga

Neuronetics Launches First Inaugural National TMS Therapy Awareness Day During Mental Health Awareness Month

May 14, 2025

From Neuronetics

Via GlobeNewswire

Evernorth Health Services, a Cigna Company, Expands NeuroStar® TMS Coverage for Adolescents Struggling with Depression

March 31, 2025

Policy update increases access for millions covered by Evernorth Health Services

From Neuronetics

Via GlobeNewswire

What's going on in today's pre-market session ↗

February 07, 2025

Discover the top movers in Friday's pre-market session and stay informed about market dynamics.

Via Chartmill

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

February 07, 2025

Via Benzinga

Earnings Scheduled For March 4, 2025 ↗

March 04, 2025

Via Benzinga

These stocks are moving in today's after hours session ↗

February 06, 2025

Let's have a look at what is happening on the US markets after the closing bell on Thursday. Below you can find the top gainers and losers in today's after hours session.

Via Chartmill

NeuroStar Unveils Two Significant Publications on TMS Therapy for Depression

January 29, 2025

Advancing mental health treatment through innovative research, offering insights on symptom improvement and clinical tools

From Neuronetics

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

November 12, 2024

Via Benzinga

NeuroStar® Oral Presentation at AACAP 2024 Highlights Largest Study Evaluating TMS Efficacy in Adolescents with Depression

October 14, 2024

Data selected for oral presentation reinforce previous findings on safety and efficacy

From Neuronetics

Via GlobeNewswire

Health Care Service Corporation Adds First-Line TMS Coverage for Adolescents

September 25, 2024

Policy update increases access for millions covered by HCSC BlueCross BlueShield policies

From Neuronetics

Via GlobeNewswire

Expanded Health Policies Enhance TMS Therapy Access for Adolescents and Adults

September 19, 2024

BlueCross BlueShield of North Carolina and Louisiana Medicaid Increase Coverage for Patients with Depression

From Neuronetics

Via GlobeNewswire

NeuroStar® Releases Software Upgrades to Elevate Patient Care

September 16, 2024

Upgrades improve communication, streamline data management, and strengthen security

From Neuronetics

Via GlobeNewswire

Retractable Technologies And 2 Other Penny Stocks Executives Are Buying ↗

September 09, 2024

Via Benzinga

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Enstar Group Limited (Nasdaq – ESGR), PetIQ, Inc. (Nasdaq – PETQ), Greenbrook TMS, Inc. (OTC – GBNHF), GSE Solutions, Inc. (Nasdaq – GVP)

September 06, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

NeuroStar Honors Suicide Prevention Month With Milestone Achievement and Powerful Stories

September 03, 2024

NeuroStar Is More Than Halfway to Achieving Its Five-Year Goal of Saving Thousands of Lives

From Neuronetics

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Neuronetics, Inc. - Common Stock (NQ:STIM)

All News about Neuronetics, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today